---
title: "Pathify.ai Director Increases Indirect Shareholding Through Placement"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275078656.md"
description: "Pathify.ai Ltd has announced that director Paul Niardone increased his indirect shareholding through Trindis Pty Ltd by acquiring 2,000,000 fully paid ordinary shares at $0.012 each, totaling $24,000. He now holds 2,000,000 shares and 2,000,000 unlisted options. This transaction reflects continued director participation in capital raisings, signaling confidence in the company's prospects. Pathify.ai Ltd is an ASX-listed company, but specific details about its operations are not provided."
datetime: "2026-02-06T05:58:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275078656.md)
  - [en](https://longbridge.com/en/news/275078656.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275078656.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275078656.md) | [繁體中文](https://longbridge.com/zh-HK/news/275078656.md)


# Pathify.ai Director Increases Indirect Shareholding Through Placement

### Claim 50% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Opyl Ltd. ( (AU:PKY) ) has shared an announcement.

Pathify.ai Ltd has disclosed a change in director Paul Niardone’s interests, with the director’s relevant interest held indirectly through Trindis Pty Ltd. While the notice does not detail the company’s operations, it confirms Niardone’s ongoing stake via both fully paid ordinary shares and unlisted options, clarifying his financial alignment with shareholders. The filing reports that on 4 February 2026 Niardone, via Trindis Pty Ltd, acquired 2,000,000 fully paid ordinary shares in a recent share placement at $0.012 per share, for total consideration of $24,000, and now holds 2,000,000 shares plus 2,000,000 unlisted options exercisable at $0.03 expiring on 20 August 2029. The transaction underscores continued director participation in capital raisings, which may be read by investors as a signal of confidence in the company’s prospects and governance alignment, although it does not alter any contractual interests.

**More about Opyl Ltd.**

Pathify.ai Ltd (formerly Opyl Ltd) is an ASX-listed company; however, this notice does not provide specific details on its industry, products, or services.

**Average Trading Volume:** 612,686

**Technical Sentiment Signal:** Sell

**Current Market Cap:** A$12.14M

For an in-depth examination of PKY stock, go to TipRanks’ Overview page.

## Related News & Research

- [BullFrog AI Signs Major AI Drug Discovery Partnership](https://longbridge.com/en/news/281092205.md)
- [2 AI Healthcare Stocks to Buy Right Now](https://longbridge.com/en/news/281175311.md)
- [Dewa Resumes Trading on Dubai Bourse](https://longbridge.com/en/news/281521763.md)
- [MedPal AI Wins Strong Shareholder Backing at AGM as It Expands AI Health Platform](https://longbridge.com/en/news/281501359.md)
- [Tempus AI, Medtronic Report Positive Clinical Trial Results for Medical Alert System](https://longbridge.com/en/news/281383602.md)